{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T11:57:19Z","timestamp":1793361439058,"version":"4.5.0"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016126","name":"Beijing Hospital Authority","doi-asserted-by":"publisher","award":["DFL20191601"],"award-info":[{"award-number":["DFL20191601"]}],"id":[{"id":"10.13039\/100016126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016126","name":"Beijing Hospital Authority","doi-asserted-by":"publisher","award":["ZYLX202122)"],"award-info":[{"award-number":["ZYLX202122)"]}],"id":[{"id":"10.13039\/100016126","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Despite the widespread use of standardised drug regimens, advanced diagnostics, and <jats:italic>Mycobacterium bovis<\/jats:italic> Bacille-Calmette-Gu\u00e9rin (BCG) vaccines, the global tuberculosis (TB) epidemic remains uncontrollable. To address this challenge, improved vaccines are urgently required that can elicit persistent immunologic memory, the hallmark of successful vaccines. Nonetheless, the processes underlying the induction and maintenance of immunologic memory are not entirely understood. Clarifying how memory T cells (Tm cells) are created and survive long term may be a crucial step towards the development of effective T cell\u2013targeted vaccines. Here, we review research findings on the memory T cell response, which involves mobilization of several distinct Tm cell subsets that are required for efficient host suppression of <jats:italic>M. tuberculosis<\/jats:italic> (Mtb) activity. We also summaries current knowledge related to the T cell response-based host barrier against Mtb infection and discuss advantages and disadvantages of novel TB vaccine candidates.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1100741","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T07:02:28Z","timestamp":1680246148000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Maintenance and recall of memory T cell populations against tuberculosis: Implications for vaccine design"],"prefix":"10.3389","volume":"14","author":[{"given":"Xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S2213-2600(19)30418-7","article-title":"WHO global progress report on tuberculosis elimination","volume":"8","author":"Harding","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/4.5.916","article-title":"A successful eradication campaign","volume":"4","author":"Fenner","year":"1982","journal-title":"Global eradication smallpox. Rev Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: Historical successes and current challenges","author":"Minor","year":"2015","journal-title":"Virology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/90643","article-title":"CD4(+) T cell effectors can become memory cells with high efficiency and without further division","volume":"2","author":"Hu","year":"2001","journal-title":"Nat Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","first-page":"a037879","DOI":"10.1101\/cshperspect.a037879","article-title":"Homeostasis of naive and memory T lymphocytes","volume":"13","author":"Kawabe","year":"2021","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.11.009","article-title":"CD8(+) T cells utilize highly dynamic enhancer repertoires and regulatory circuitry in response to infections","volume":"45","author":"He","year":"2016","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.imlet.2017.10.014","article-title":"Evaluation of profile and functionality of memory T cells in pulmonary tuberculosis","volume":"192","author":"Tonaco","year":"2017","journal-title":"Immunol Lett"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12833","article-title":"Altered expression of antigen-specific memory and regulatory T-cell subsets differentiate latent and active tuberculosis","volume":"153","author":"Pathakumari","year":"2018","journal-title":"Immunology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015619","article-title":"Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis","volume":"5","author":"Casey","year":"2010","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.8.5217","article-title":"Dynamic relationship between IFN-gamma and IL-2 profile of mycobacterium tuberculosis-specific T cells and antigen load","volume":"178","author":"Millington","year":"2007","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.929947","article-title":"Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future","volume":"13","author":"Smaill","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant bacille calmette-gu\u00e9rin vaccine VPM1002: Ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.06.049","article-title":"MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG","volume":"39","author":"Mart\u00edn","year":"2021","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/vaccines10050825","article-title":"Therapeutic effect of subunit vaccine AEC\/BC02 on mycobacterium tuberculosis post-chemotherapy relapse using a latent infection murine model","volume":"10","author":"Lu","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.134","article-title":"Double-blind, randomized, placebo-controlled phase I clinical trial of the therapeutical antituberculous vaccine RUTI","volume":"28","author":"Vilaplana","year":"2010","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"117594","DOI":"10.1016\/j.lfs.2020.117594","article-title":"Tuberculosis vaccine: A journey from BCG to present","volume":"252","author":"Fatima","year":"2020","journal-title":"Life Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.055","article-title":"DAR-901 vaccine for the prevention of infection with mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial","volume":"38","author":"Munseri","year":"2020","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9949-3","article-title":"A randomized, controlled dose-finding phase II study of the M72\/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults","volume":"33","author":"Montoya","year":"2013","journal-title":"J Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1038\/s41467-021-27029-6","article-title":"A phase I\/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients","volume":"12","author":"Jenum","year":"2021","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30319-2","article-title":"Safety and immunogenicity of the adjunct therapeutic vaccine ID93\u2008+\u2008GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"9","author":"Day","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/vaccines8040652","article-title":"Safety and immunogenicity of the GamTBvac, the recombinant subunit tuberculosis vaccine candidate: A phase II, multi-center, double-blind, randomized, placebo-controlled study","volume":"8","author":"Tkachuk","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"van Dissel","year":"2014","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of m. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-020-01320-6","article-title":"Tissue-resident memory T cells in the skin","volume":"69","author":"Khalil","year":"2020","journal-title":"Inflammation Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e142014","DOI":"10.1172\/JCI142014","article-title":"Tissue-resident-like CD4+ T cells secreting IL-17 control mycobacterium tuberculosis in the human lung","volume":"131","author":"Ogongo","year":"2021","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.035","article-title":"Induction and maintenance of a phenotypically heterogeneous lung tissue-resident CD4(+) T cell population following BCG immunisation","volume":"36","author":"Bull","year":"2018","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.11.004","article-title":"Interleukin-2-Dependent allergen-specific tissue-resident memory cells drive asthma","volume":"44","author":"Hondowicz","year":"2016","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0494-y","article-title":"CD103(hi) t(reg) cells constrain lung fibrosis induced by CD103(lo) tissue-resident pathogenic CD4 T cells","volume":"20","author":"Ichikawa","year":"2019","journal-title":"Nat Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"eabc8122","DOI":"10.1126\/sciimmunol.abc8122","article-title":"Resident memory T cells form during persistent antigen exposure leading to allograft rejection","volume":"6","author":"Abou-Daya","year":"2021","journal-title":"Sci Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040310","article-title":"Modulating numbers and phenotype of CD8+ T cells in secondary immune responses","volume":"40","author":"Wirth","year":"2010","journal-title":"Eur J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5MR0321-145R","article-title":"Stem cell-like memory T cells: The generation and application","volume":"110","author":"Wang","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008356","article-title":"Clofazimine enhances the efficacy of BCG revaccination via stem cell-like memory T cells","volume":"16","author":"Ahmad","year":"2020","journal-title":"PloS Pathog"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu347","article-title":"Central memory CD4+ T cells are responsible for the recombinant bacillus calmette-gu\u00e9rin \u0394ureC::hly vaccine\u2019s superior protection against tuberculosis","volume":"210","author":"Vogelzang","year":"2014","journal-title":"J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.06.014","article-title":"Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation","volume":"33","author":"Wirth","year":"2010","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2010.06.002","article-title":"The Achilles heel of BCG","volume":"90","author":"Orme","year":"2010","journal-title":"Tuberculosis (Edinb)."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00368-09","article-title":"Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with mycobacterium tuberculosis","volume":"17","author":"Henao-Tamayo","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.004","article-title":"BCG-Prime and boost with esx-5 secretion system deletion mutant leads to better protection against clinical strains of mycobacterium tuberculosis","volume":"38","author":"Tiwari","year":"2020","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1573","article-title":"Resistance and tolerance of mycobacterium tuberculosis to antimicrobial agents-how m. tuberculosis can escape antibiotics","volume":"14","author":"Li","year":"2022","journal-title":"WIREs Mech Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw395","article-title":"Blockade of the Kv1.3 k+ channel enhances BCG vaccine efficacy by expanding central memory T lymphocytes","volume":"214","author":"Singh","year":"2016","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269109","article-title":"Dominant expansion of CD4+, CD8+ T and NK cells expressing Th1\/Tc1\/Type 1 cytokines in culture-positive lymph node tuberculosis","volume":"17","author":"Kathamuthu","year":"2022","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/518660","article-title":"Tuberculosis and HIV infection: the global setting","author":"Nunn","year":"2007","journal-title":"J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","article-title":"Pathogenesis of HIV-1 and mycobacterium tuberculosis co-infection","volume":"16","author":"Bell","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.8.4501-4509.2002","article-title":"Dissemination of mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity","volume":"70","author":"Chackerian","year":"2002","journal-title":"Infect Immun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071367","article-title":"Initiation of the adaptive immune response to mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs","volume":"205","author":"Wolf","year":"2008","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.13.3325","article-title":"The apoptotic signaling pathway activated by toll-like receptor-2","volume":"19","author":"Aliprantis","year":"2000","journal-title":"EMBO J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chom.2015.12.003","article-title":"Antigen export reduces antigen presentation and limits T cell control of m. tuberculosis","volume":"19","author":"Srivastava","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13488","article-title":"Emerging patterns of regulatory T cell function in tuberculosis","volume":"202","author":"Ahmed","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091885","article-title":"Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis","volume":"207","author":"Shafiani","year":"2010","journal-title":"J Exp Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.micres.2017.01.004","article-title":"Mycobacterium tuberculosis Rv1987 induces Th2 immune responses and enhances mycobacterium smegmatis survival in mice","volume":"197","author":"Sha","year":"2017","journal-title":"Microbiol Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005490","article-title":"TIM3 mediates T cell exhaustion during mycobacterium tuberculosis infection","volume":"12","author":"Jayaraman","year":"2016","journal-title":"PloS Pathog"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2016.1185603","article-title":"T-Cell exhaustion in tuberculosis: pitfalls and prospects","volume":"43","author":"Khan","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.138.2.491","article-title":"In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma","volume":"138","author":"Black","year":"1987","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"109696","DOI":"10.1016\/j.celrep.2021.109696","article-title":"CD4 T cell help prevents CD8 T cell exhaustion and promotes control of mycobacterium tuberculosis infection","volume":"36","author":"Lu","year":"2021","journal-title":"Cell Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113951","article-title":"Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice","volume":"9","author":"Nandakumar","year":"2014","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1849","article-title":"Reversing T-cell dysfunction and exhaustion in cancer","volume":"22","author":"Zarour","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ccell.2017.05.010","article-title":"SnapShot: Immune checkpoint inhibitors","volume":"31","author":"Abril-Rodriguez","year":"2017","journal-title":"Cancer Cell"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2006.0103","article-title":"IFN-gamma therapy of tuberculosis and related infections","volume":"27","author":"Reljic","year":"2007","journal-title":"J Interferon Cytokine Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30674-6","article-title":"Immune checkpoint inhibitors and tuberculosis: an old disease in a new context","volume":"21","author":"Langan","year":"2020","journal-title":"Lancet Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2018.1457439","article-title":"The use of immunotherapy for the treatment of tuberculosis","volume":"12","author":"Ramos-Espinosa","year":"2018","journal-title":"Expert Rev Respir Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2009.08.009","article-title":"Advances in immunotherapy for tuberculosis treatment","volume":"30","author":"Churchyard","year":"2009","journal-title":"Clin Chest Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30251-6","article-title":"Live-attenuated mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial","volume":"7","author":"Tameris","year":"2019","journal-title":"Lancet Respir Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01686-16","article-title":"Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis","volume":"7","author":"Perdomo","year":"2016","journal-title":"mBio"},{"key":"B69","doi-asserted-by":"publisher","first-page":"100187","DOI":"10.1016\/j.xcrm.2020.100187","article-title":"Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection","volume":"2","author":"Dijkman","year":"2021","journal-title":"Cell Rep Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/vaccines8040715","article-title":"Fusion cytokines IL-7-Linker-IL-15 promote mycobacterium tuberculosis subunit vaccine to induce central memory like T cell-mediated immunity","volume":"8","author":"Bai","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0145-5","article-title":"Mucosal boosting of H56:CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to mycobacterium tuberculosis infection without enhancing vaccine protection","volume":"12","author":"Woodworth","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.609624","article-title":"Characterization and monitoring of antigen-responsive T cell clones using T cell receptor gene expression analysis","volume":"11","author":"Pollastro","year":"2020","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.chom.2017.05.012","article-title":"Antigen availability shapes T cell differentiation and function during tuberculosis","volume":"21","author":"Moguche","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1023970","article-title":"A high ratio of IC31(\u00ae) adjuvant to antigen is necessary for H4 TB vaccine immunomodulation","volume":"11","author":"Aboutorabian","year":"2015","journal-title":"Hum Vaccin Immunother."},{"key":"B75","doi-asserted-by":"publisher","first-page":"102186","DOI":"10.1016\/j.tube.2022.102186","article-title":"Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster","volume":"134","author":"Mao","year":"2022","journal-title":"Tuberculosis (Edinb)."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087340","article-title":"The candidate TB vaccine, MVA85A, induces highly durable Th1 responses","volume":"9","author":"Tameris","year":"2014","journal-title":"PloS One"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12275","article-title":"The generation of T-cell memory to protect against tuberculosis","volume":"97","author":"Counoupas","year":"2019","journal-title":"Immunol Cell Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1100741\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T07:02:33Z","timestamp":1680246153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1100741\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":77,"alternative-id":["10.3389\/fimmu.2023.1100741"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1100741","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"article-number":"1100741"}}